Literature DB >> 6282971

A role for oxygen-dependent mechanisms in killing of Leishmania donovani tissue forms by activated macrophages.

C G Haidaris, P F Bonventre.   

Abstract

Leishmania donovani, the causative agent of visceral leishmaniasis, infects macrophages (M phi ) of susceptible vertebrates. Immunologically activated M phi are leishmanicidal, but the mechanisms involved in the killing process are not well defined. We sought to investigate the role of reactive oxygen intermediates in the killing of L. donovani. Both the free-swimming promastigote and the intracellular amastigote forms were found to be susceptible to killing in vitro by hydrogen peroxide and other oxygen intermediates. Upon phagocytosis by mouse peritoneal M phi, promastigotes elicited a significantly stronger respiratory burst compared with amastigotes as measured by release of superoxide anion. Although amastigotes do not elicit a strong burst of M phi oxidative metabolism during the initial phagocytic event, immunologically activated M phi that acquired leishmanicidal capacity could be triggered to release substantial amounts of H2O2. Hence, the development of leishmanicidal capacity was correlated temporally with enhanced H2O2 generation by the M phi. In contrast, M phi that lost their ability to release significant amounts of H2O2 after several days in culture were unable to eliminate their parasite burden. Catalase markedly inhibited the elimination of amastigotes by lymphokine-stimulated M phi. In toto, the results implicate reactive oxygen intermediates in killing of the tissue form of L. donovani by its host cell, the mononuclear phagocyte.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6282971

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  25 in total

1.  Leishmania pifanoi amastigotes avoid macrophage production of superoxide by inducing heme degradation.

Authors:  Nam-Kha Pham; Jennifer Mouriz; Peter E Kima
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

2.  Human classical monocytes control the intracellular stage of Leishmania braziliensis by reactive oxygen species.

Authors:  Fernanda O Novais; Ba T Nguyen; Daniel P Beiting; Lucas P Carvalho; Nelson D Glennie; Sara Passos; Edgar M Carvalho; Phillip Scott
Journal:  J Infect Dis       Date:  2014-01-07       Impact factor: 5.226

Review 3.  Biochemistry of the Leishmania species.

Authors:  R H Glew; A K Saha; S Das; A T Remaley
Journal:  Microbiol Rev       Date:  1988-12

4.  Treatment of alveolar macrophages with cytochalasin D inhibits uptake and subsequent growth of Legionella pneumophila.

Authors:  J A Elliott; W C Winn
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

5.  Visceral leishmaniasis associated with chronic granulomatous disease.

Authors:  M Mauri Pont; C Sánchez Rodríguez; F Bella Cueto; J Espaulella Panicot; J Homs Brubenga
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-02       Impact factor: 3.267

6.  Acid phosphatase activity in Coxiella burnetii: a possible virulence factor.

Authors:  O G Baca; M J Roman; R H Glew; R F Christner; J E Buhler; A S Aragon
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

7.  Heterogeneous activity of immature and mature cells of the murine monocyte-macrophage lineage derived from different anatomical districts against yeast-phase Candida albicans.

Authors:  T Decker; M L Lohmann-Matthes; M Baccarini
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

8.  Impairment of the oxidative metabolism of mouse peritoneal macrophages by intracellular Leishmania spp.

Authors:  Y Buchmüller-Rouiller; J Mauël
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

9.  Macrophage activation by polymeric nanoparticles of polyalkylcyanoacrylates: activity against intracellular Leishmania donovani associated with hydrogen peroxide production.

Authors:  R Gaspar; V Préat; F R Opperdoes; M Roland
Journal:  Pharm Res       Date:  1992-06       Impact factor: 4.200

10.  Resistance to cutaneous leishmaniasis: acquired ability of the host to kill parasites at the site of infection.

Authors:  J O Hill
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.